FDA recall,
KM Pharmaceutical Foamgle Mouthwash, Super Mint
Foamgle Mouthwash, Super Mint was made with steps that were not done the way the federal manufacturing rules require.
What to do
Check yoursIf a code on your package is listed below:
- Stop using it and check the lot against the recall notice.
Typical advice for a recalled product like this; the FDA notice gives no product-specific instructions.
What happened
KM Pharmaceutical Co., Ltd., of Pyeongtaek, Korea (the Republic of), is recalling 11,000 bottles of foamgle Mouthwash, Super Mint (Allantoin 0.05%). The reason is a manufacturing problem: steps were not done the way the federal rules for how products like this must be made require. The company started the recall on its own on November 10, 2026, and told customers by letter.
The bottles were distributed nationwide in the USA. The FDA added the recall to its Enforcement Report on November 18, 2026.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
foamgle Mouthwash, Super Mint
- NDC
- 50555-210-02
- 50555-210-01
- Lot code
- EF10A
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 16, 2026
- Sold in
Distributed nationwide.
- Recalled by
- KM Pharmaceutical Co., Ltd.Pyeongtaek, Korea (the Republic of)
- Hazard
- Manufacturing problem
- Risk
Not yet rated by FDA
- FDA event number
- 100319
- Quantity recalled
- 11,000 bottles
- Recall type
- Started by the company
- How the company first told customers
- Letter
All recalls from KM Pharmaceutical Co., Ltd.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
KM PHARMACEUTICAL began the recall
FDA posted the recall to its Enforcement Report
Added to Recall Canary



